Precigen Reports First Quarter 2023 Financial Results and Business Updates
– Positive Phase 1 clinical data presented for PRGN-2012 AdenoVerse™ immunotherapy in RRP demonstrated favorable safety profile and significant reduction in...
Stay updated with breaking news from Positive Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Positive Phase 1 clinical data presented for PRGN-2012 AdenoVerse™ immunotherapy in RRP demonstrated favorable safety profile and significant reduction in...
/PRNewswire/ -- Aisa Pharma, Inc. a private, clinical-stage biopharmaceutical company, today announced it will present data on its clinical drug candidate,...
OSE Immunotherapeutics Updates on Anti-IL-7 Receptor Antagonist OSE-127/S95011, a Breakthrough Approach in Chronic Inflammatory Autoimmune Diseases and Hematology· Positive Phase 1 clinical results published in 'The Journal of Immunology’ (online)· &...
Positive Phase 1 clinical results published in 'The Journal of Immunology' (online) Two ongoing Phase 2 clinical trials in Ulcerative Colitis and primary Sjögren's Syndrome Positive
Ad hoc announcement pursuant to Art. 53 LRAllschwil, Switzerland – October 25, 2022Idorsia Ltd (SIX: IDIA) today announced its financial results for the...